Make smart decisions about your research projects.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.

Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.

Targeting inflammation to fight cancer is a new approach with a long history.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.